009290 — Kwangdong Pharmaceutical Co Cashflow Statement
0.000.00%
Last trade - 00:00- KR₩236bn
- KR₩353bn
- KR₩2tn
- 63
- 74
- 74
- 85
Annual cashflow statement for Kwangdong Pharmaceutical Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 45,602 | 25,541 | 26,701 | 39,372 | 41,845 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 15,824 | 30,609 | 30,761 | 18,340 | 1,428 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -58,235 | -15,248 | -8,588 | -82,278 | -69,836 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 22,829 | 54,940 | 62,822 | -11,730 | -12,153 |
| Capital Expenditures | -5,303 | -24,447 | -26,039 | -35,158 | -77,793 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -42,257 | -18,529 | -16,707 | -36,673 | 90,565 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Sale of Intangible Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -47,560 | -42,976 | -42,747 | -71,831 | 12,772 |
| Financing Cash Flow Items | — | -85.5 | -10.5 | 1,010 | 1,150 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 3,838 | 15,894 | -628 | 58,010 | 36,765 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -21,399 | 29,084 | 19,587 | -26,208 | 38,845 |